• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2020

View Archived Issues

AI finds structurally unique antibiotics

Read More

New dihydroquinoxalinone analogues targeting tubulin with promising preclinical antitumor action

Read More

New receptor tyrosine kinase inhibitor acts as a broad-spectrum coronavirus inhibitor in vitro

Read More

Neuronal necrosis induced by YAP deprivation mostly occurs in early stages of Alzheimer's disease

Read More

FDA approves Nexlizet tablet as first non-statin LDL-C lowering combination medicine

Read More

Positive top-line results for phase III ALLIUM study of Exblifep for cUTI

Read More

Novel alphaVbetea6-targeted PDC shows promise in preclinical models of PDAC

Read More

Progranulin as a novel prognostic biomarker in community-acquired pneumonia

Read More

Phase I data for novel lentiviral vector therapy for children with Fanconi anemia

Read More

First patient enrolled in first-in-human study of NI-006

Read More

Dosing begins in phase I study of KAN-101 for the treatment of celiac disease

Read More

CD5.CAR/28zeta CAR T cells show antitumor activity in relapsed/refractory T-cell lymphoma

Read More

FDA approves IND and grants orphan drug status for HBM-9167

Read More

Boehringer Ingelheim Pharma patents KLKB1 inhibitors

Read More

Microglial fresh start helps heal brain trauma

Read More

Inflazome divulges new NLRP3 inflammasome inhibitors

Read More

Leo Pharma A/S presents RORC ligands

Read More

Amgen and Carmot Therapeutics identify USP30 inhibitors

Read More

Epizyme discloses new SETD2 inhibitors

Read More

DNA-PKcs inhibitor increases the antitumor activity of localized DNA-damaging therapies

Read More

S1PR1 is required for tumor vascular normalization, enhancing the efficiency of antitumor agents

Read More

Clene announces interim blinded data from phase II study of CNM-Au8 for vision impairment in MS

Read More

Spark Therapeutics opens enrollment in phase I/II study of SPK-3006 in late-onset Pompe disease

Read More

FDA approves Nurtec ODT for acute treatment of migraine

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe